DNA X, Inc. (SONM) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2024 | $48.38M | -34.9% |
| 2023 | $74.31M | +27.7% |
| 2022 | $58.20M | +20.9% |
| 2021 | $48.16M | -1.3% |
| 2020 | $48.78M | -40.3% |
| 2019 | $81.74M | -6.7% |
| 2018 | $87.58M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2024 | $48.38M | -34.9% |
| 2023 | $74.31M | +27.7% |
| 2022 | $58.20M | +20.9% |
| 2021 | $48.16M | -1.3% |
| 2020 | $48.78M | -40.3% |
| 2019 | $81.74M | -6.7% |
| 2018 | $87.58M | — |